vs
Purple Innovation, Inc.（PRPL）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是Purple Innovation, Inc.的1.1倍（$151.7M vs $140.7M），Purple Innovation, Inc.净利率更高（-2.3% vs -5.5%，领先3.2%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 9.1%），Tarsus Pharmaceuticals, Inc.自由现金流更多（$13.0M vs $-7.8M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 8.3%）
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
PRPL vs TARS — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.7M | $151.7M |
| 净利润 | $-3.2M | $-8.4M |
| 毛利率 | 41.9% | — |
| 营业利润率 | -1.6% | -5.3% |
| 净利率 | -2.3% | -5.5% |
| 营收同比 | 9.1% | 128.4% |
| 净利润同比 | 62.1% | 63.8% |
| 每股收益（稀释后） | $0.03 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $140.7M | $151.7M | ||
| Q3 25 | $118.8M | $118.7M | ||
| Q2 25 | $105.1M | $102.7M | ||
| Q1 25 | $104.2M | $78.3M | ||
| Q4 24 | $129.0M | $66.4M | ||
| Q3 24 | $118.6M | $48.1M | ||
| Q2 24 | $120.3M | $40.8M | ||
| Q1 24 | $120.0M | $27.6M |
| Q4 25 | $-3.2M | $-8.4M | ||
| Q3 25 | $-11.7M | $-12.6M | ||
| Q2 25 | $-17.3M | $-20.3M | ||
| Q1 25 | $-19.1M | $-25.1M | ||
| Q4 24 | $-8.5M | $-23.1M | ||
| Q3 24 | $-39.2M | $-23.4M | ||
| Q2 24 | $27.0K | $-33.3M | ||
| Q1 24 | $-50.2M | $-35.7M |
| Q4 25 | 41.9% | — | ||
| Q3 25 | 42.8% | — | ||
| Q2 25 | 35.9% | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.9% | — | ||
| Q3 24 | 29.7% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 34.8% | — |
| Q4 25 | -1.6% | -5.3% | ||
| Q3 25 | -10.2% | -12.2% | ||
| Q2 25 | -13.5% | -21.6% | ||
| Q1 25 | -13.9% | -33.5% | ||
| Q4 24 | -6.0% | -36.8% | ||
| Q3 24 | -39.5% | -52.3% | ||
| Q2 24 | -12.1% | -81.6% | ||
| Q1 24 | -19.3% | -136.5% |
| Q4 25 | -2.3% | -5.5% | ||
| Q3 25 | -9.9% | -10.6% | ||
| Q2 25 | -16.5% | -19.8% | ||
| Q1 25 | -18.4% | -32.1% | ||
| Q4 24 | -6.6% | -34.8% | ||
| Q3 24 | -33.1% | -48.7% | ||
| Q2 24 | 0.0% | -81.6% | ||
| Q1 24 | -41.8% | -129.4% |
| Q4 25 | $0.03 | $-0.17 | ||
| Q3 25 | $0.11 | $-0.30 | ||
| Q2 25 | $0.16 | $-0.48 | ||
| Q1 25 | $0.18 | $-0.64 | ||
| Q4 24 | $0.08 | $-0.57 | ||
| Q3 24 | $0.36 | $-0.61 | ||
| Q2 24 | $0.00 | $-0.88 | ||
| Q1 24 | $0.47 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.3M | $417.3M |
| 总债务越低越好 | $126.7M | $72.4M |
| 股东权益账面价值 | $-29.7M | $343.4M |
| 总资产 | $296.3M | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
| Q4 25 | $24.3M | $417.3M | ||
| Q3 25 | $32.4M | $401.8M | ||
| Q2 25 | $34.2M | $381.1M | ||
| Q1 25 | $21.6M | $407.9M | ||
| Q4 24 | $29.0M | $291.4M | ||
| Q3 24 | $23.4M | $317.0M | ||
| Q2 24 | $23.4M | $323.6M | ||
| Q1 24 | $34.5M | $298.5M |
| Q4 25 | $126.7M | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | $70.7M | $71.8M | ||
| Q3 24 | $50.8M | $71.7M | ||
| Q2 24 | — | $71.6M | ||
| Q1 24 | — | $29.9M |
| Q4 25 | $-29.7M | $343.4M | ||
| Q3 25 | $-26.9M | $335.1M | ||
| Q2 25 | $-15.6M | $332.6M | ||
| Q1 25 | $1.3M | $342.5M | ||
| Q4 24 | $20.2M | $224.5M | ||
| Q3 24 | $28.0M | $237.5M | ||
| Q2 24 | $66.4M | $252.2M | ||
| Q1 24 | $65.5M | $275.2M |
| Q4 25 | $296.3M | $562.2M | ||
| Q3 25 | $302.1M | $534.6M | ||
| Q2 25 | $303.8M | $495.0M | ||
| Q1 25 | $293.8M | $500.8M | ||
| Q4 24 | $307.8M | $377.0M | ||
| Q3 24 | $309.3M | $376.3M | ||
| Q2 24 | $362.1M | $376.8M | ||
| Q1 24 | $382.1M | $349.3M |
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | 3.50× | 0.32× | ||
| Q3 24 | 1.82× | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $-7.8M | $13.0M |
| 自由现金流率自由现金流/营收 | -5.5% | 8.6% |
| 资本支出强度资本支出/营收 | 1.4% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.9M | $-22.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-5.8M | $19.3M | ||
| Q3 25 | $-968.0K | $18.3M | ||
| Q2 25 | $-4.0M | $-29.4M | ||
| Q1 25 | $-23.1M | $-20.7M | ||
| Q4 24 | $6.8M | $-22.2M | ||
| Q3 24 | $1.1M | $-8.7M | ||
| Q2 24 | $-8.9M | $-14.4M | ||
| Q1 24 | $-16.8M | $-37.8M |
| Q4 25 | $-7.8M | $13.0M | ||
| Q3 25 | $-1.8M | $16.3M | ||
| Q2 25 | $-7.0M | $-30.4M | ||
| Q1 25 | $-25.3M | $-21.2M | ||
| Q4 24 | $5.7M | $-22.3M | ||
| Q3 24 | $101.0K | $-8.9M | ||
| Q2 24 | $-11.0M | $-15.4M | ||
| Q1 24 | $-19.9M | $-38.0M |
| Q4 25 | -5.5% | 8.6% | ||
| Q3 25 | -1.5% | 13.8% | ||
| Q2 25 | -6.6% | -29.6% | ||
| Q1 25 | -24.3% | -27.1% | ||
| Q4 24 | 4.4% | -33.5% | ||
| Q3 24 | 0.1% | -18.6% | ||
| Q2 24 | -9.2% | -37.8% | ||
| Q1 24 | -16.5% | -137.5% |
| Q4 25 | 1.4% | 4.2% | ||
| Q3 25 | 0.7% | 1.6% | ||
| Q2 25 | 2.8% | 1.0% | ||
| Q1 25 | 2.2% | 0.8% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | 0.9% | 0.6% | ||
| Q2 24 | 1.7% | 2.5% | ||
| Q1 24 | 2.5% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -330.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
TARS
暂无分部数据
